{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:37:18Z","timestamp":1784590638536,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-024-05209-1","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T16:20:36Z","timestamp":1734970836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)"],"prefix":"10.1186","volume":"23","author":[{"given":"Alicia P. C.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A. M.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P. S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela N.","family":"D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiran S. S.","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evellyn A. R. T.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio A.","family":"Amazonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia C. S.","family":"Balieiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene","family":"Rufatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Grewal Daumerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssio R. L.","family":"Peterka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dh\u00e9lio","family":"Batista Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V. G.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe L. G.","family":"Murta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"5209_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pt.2018.11.011","volume":"35","author":"XH Li","year":"2019","unstructured":"Li XH, Kondrashin A, Greenwood B, Lindblade K, Loku Galappaththy G, Alonso P. A historical review of WHO certification of malaria elimination. Trends Parasitol. 2019;35:163\u201371.","journal-title":"Trends Parasitol"},{"key":"5209_CR2","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023. Accessed 8 Jan 2024."},{"key":"5209_CR3","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1016\/S2214-109X(21)00007-3","volume":"9","author":"JC Gabaldon-Figueira","year":"2021","unstructured":"Gabaldon-Figueira JC, Villegas L, Grillet ME, Lezaun J, Pocaterra L, Bevilacqua M, et al. Malaria in Venezuela: Gabaldon\u2019s legacy scattered to the winds. Lancet Glob Health. 2021;9:e584\u20135.","journal-title":"Lancet Glob Health"},{"key":"5209_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12936-017-1925-6","volume":"16","author":"J Recht","year":"2017","unstructured":"Recht J, Siqueira AM, Monteiro WM, Herrera SM, Herrera S, Lacerda MVG. Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination. Malar J. 2017;16:273.","journal-title":"Malar J"},{"key":"5209_CR5","unstructured":"PAHO, WHO. Brazil launches national plan to eliminate malaria in the country, with support from PAHO. Washington: Pan American Health Organization, Geneva: World Health Organization; 2022. https:\/\/www.paho.org\/pt\/noticias\/12-5-2022-brasil-lanca-plano-nacional-para-eliminacao-da-malaria-no-pais-com-apoio-da-opas. Accessed 17 July 2024."},{"key":"5209_CR6","unstructured":"Secretaria de Vigil\u00e2ncia em Sa\u00fade, Minist\u00e9rio da Sa\u00fade. Panorama epidemiol\u00f3gico da mal\u00e1ria em 2021: buscando o caminho para a elimina\u00e7\u00e3o da mal\u00e1ria no Brasil. Boletim Epidemiol\u00f3gico. 2022;53:1\u201329."},{"key":"5209_CR7","doi-asserted-by":"crossref","unstructured":"Balieiro AAS, Siqueira AM, Melo GC, Monteiro WM, Sampaio VS, Mueller I, et al. Short-time recurrences of Plasmodium vivax malaria as a public health proxy for chloroquine-resistance surveillance: a spatio-temporal study in the Brazilian Amazon. Int J Environ Res Public Health. 2021;18.","DOI":"10.3390\/ijerph18105061"},{"key":"5209_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1590\/0037-8682-0275-2015","volume":"49","author":"ED Almeida","year":"2016","unstructured":"Almeida ED, Vieira JL. Factors associated with non-adherence to the treatment of vivax malaria in a rural community from the Brazilian Amazon Basin. Rev Soc Bras Med Trop. 2016;49:248\u201351.","journal-title":"Rev Soc Bras Med Trop"},{"key":"5209_CR9","volume":"12","author":"JR Nascimento","year":"2022","unstructured":"Nascimento JR, Brito-Sousa JD, Almeida ACG, Melo MM, Costa MRF, Barbosa LRA, et al. Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: a region-wide screening study. Lancet Reg Health Am. 2022;12: 100273.","journal-title":"Lancet Reg Health Am"},{"key":"5209_CR10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/cid\/ciz122","volume":"69","author":"JD Brito-Sousa","year":"2019","unstructured":"Brito-Sousa JD, Santos TC, Avalos S, Fontecha G, Melo GC, Val F, et al. Clinical spectrum of primaquine-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency: a 9-year hospitalization-based study from the Brazilian Amazon. Clin Infect Dis. 2019;69:1440\u20132.","journal-title":"Clin Infect Dis"},{"key":"5209_CR11","unstructured":"Conitec. Tafenoquina para tratamento de pacientes com mal\u00e1ria por Plasmodium vivax. Bras\u00edlia, Minist\u00e9rio da Sa\u00fade; 2021. https:\/\/www.gov.br\/conitec\/pt-br\/midias\/consultas\/relatorios\/2021\/Sociedade\/resoc240_tafenoquina_malaria_final.pdf. Accessed 17 July 2024."},{"key":"5209_CR12","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1016\/S2214-109X(23)00542-9","volume":"12","author":"M Brito","year":"2024","unstructured":"Brito M, Rufatto R, Murta F, Sampaio V, Balieiro P, Baia-Silva D, et al. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis. Lancet Glob Health. 2024;12:e467\u201377.","journal-title":"Lancet Glob Health"},{"key":"5209_CR13","unstructured":"PATH. Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria. Seattle, PATH; 2023. https:\/\/www.path.org\/our-impact\/media-center\/brazil-becomes-the-first-malaria-endemic-country-to-adopt-single-dose-tafenoquine-and-standard-g6pd-test-for-the-treatment-of-relapsing-plasmodium-vivax-malaria\/. Accessed 17 July 2024."},{"key":"5209_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:215\u201328.","journal-title":"N Engl J Med"},{"key":"5209_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","volume":"383","author":"A Llanos-Cuentas","year":"2014","unstructured":"Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383:1049\u201358.","journal-title":"Lancet"},{"key":"5209_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1802537","volume":"380","author":"A Llanos-Cuentas","year":"2019","unstructured":"Llanos-Cuentas A, Lacerda MVG, Hien TT, Velez ID, Namaik-Larp C, Chu CS, et al. Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:229\u201341.","journal-title":"N Engl J Med"},{"key":"5209_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(24)00074-4","volume":"24","author":"M Brito","year":"2024","unstructured":"Brito M, Rufatto R, Brito-Sousa JD, Murta F, Sampaio V, Balieiro P, et al. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study. Lancet Infect Dis. 2024;24:629\u201338.","journal-title":"Lancet Infect Dis"},{"key":"5209_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022452","volume":"6","author":"C Pell","year":"2011","unstructured":"Pell C, Straus L, Andrew EV, Menaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS ONE. 2011;6: e22452.","journal-title":"PLoS ONE"},{"key":"5209_CR19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/pathogens11111328","volume":"11","author":"JD Brito-Sousa","year":"2022","unstructured":"Brito-Sousa JD, Murta F, Vitor-Silva S, Sampaio V, Mendes M, Souza B, et al. Quantitative G6PD deficiency screening in routine malaria diagnostic units in the Brazilian Amazon (SAFEPRIM): an operational mixed-methods study. Pathogens. 2022;11:1328.","journal-title":"Pathogens"},{"key":"5209_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13012-021-01171-7","volume":"17","author":"M Klaic","year":"2022","unstructured":"Klaic M, Kapp S, Hudson P, Chapman W, Denehy L, Story D, et al. Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework. Implement Sci. 2022;17:10.","journal-title":"Implement Sci"},{"key":"5209_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:88.","journal-title":"BMC Health Serv Res"},{"key":"5209_CR22","first-page":"439","volume":"15","author":"AK Mushi","year":"2016","unstructured":"Mushi AK, Massaga JJ, Mandara CI, Mubyazi GM, Francis F, Kamugisha M, et al. Acceptability of malaria rapid diagnostic tests administered by village health workers in Pangani District. North eastern Tanzania Malar J. 2016;15:439.","journal-title":"North eastern Tanzania Malar J"},{"key":"5209_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012197","volume":"18","author":"A Santos","year":"2024","unstructured":"Santos A, Brito M, Silva E, Rocha F, Oliveira A, Davila R, et al. Perspectives of healthcare professionals on training for quantitative G6PD testing during implementation of tafenoquine in Brazil (QualiTRuST Study). PLoS Negl Trop Dis. 2024;18: e0012197.","journal-title":"PLoS Negl Trop Dis"},{"key":"5209_CR24","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1177\/1049732320921835","volume":"30","author":"C Vindrola-Padros","year":"2020","unstructured":"Vindrola-Padros C, Johnson GA. Rapid techniques in qualitative research: a critical review of the literature. Qual Health Res. 2020;30:1596\u2013604.","journal-title":"Qual Health Res"},{"key":"5209_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13012-019-0853-y","volume":"14","author":"RC Gale","year":"2019","unstructured":"Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder LJ, et al. Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implement Sci. 2019;14:11.","journal-title":"Implement Sci"},{"key":"5209_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","volume":"36","author":"DJ Bowen","year":"2009","unstructured":"Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, et al. How we design feasibility studies. Am J Prev Med. 2009;36:452\u20137.","journal-title":"Am J Prev Med"},{"key":"5209_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533\u201344.","journal-title":"Adm Policy Ment Health"},{"key":"5209_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15: e0232076.","journal-title":"PLoS ONE"},{"key":"5209_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000837","volume":"3","author":"SA McMahon","year":"2018","unstructured":"McMahon SA, Winch PJ. Systematic debriefing after qualitative encounters: an essential analysis step in applied qualitative research. BMJ Glob Health. 2018;3: e000837.","journal-title":"BMJ Glob Health"},{"key":"5209_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12936-021-03820-0","volume":"20","author":"FLG Murta","year":"2021","unstructured":"Murta FLG, Marques LLG, Santos APC, Batista TSB, Mendes MO, Silva ED, et al. Perceptions about malaria among Brazilian gold miners in an Amazonian border area: perspectives for malaria elimination strategies. Malar J. 2021;20:286.","journal-title":"Malar J"},{"key":"5209_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"5209_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1475-2875-13-321","volume":"13","author":"ED Almeida","year":"2014","unstructured":"Almeida ED, Rodrigues LC, Vieira JL. Estimates of adherence to treatment of vivax malaria. Malar J. 2014;13:321.","journal-title":"Malar J"},{"key":"5209_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12936-019-2854-3","volume":"18","author":"FLG Murta","year":"2019","unstructured":"Murta FLG, Mendes MO, Sampaio VS, Junior ASB, Diaz-Bermudez XP, Monteiro WM, et al. Misperceptions of patients and health workers regarding malaria elimination in the Brazilian Amazon: a qualitative study. Malar J. 2019;18:223.","journal-title":"Malar J"},{"key":"5209_CR34","unstructured":"GSK. KRINTAFEL prescribing information. Durham, GSK; 2023. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Krintafel\/pdf\/KRINTAFEL-PI-PIL.PDF. Accessed 13 Mar 2024."},{"key":"5209_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12936-020-03184-x","volume":"19","author":"S Duparc","year":"2020","unstructured":"Duparc S, Chalon S, Miller S, Richardson N, Toovey S. Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review. Malar J. 2020;19:111.","journal-title":"Malar J"},{"key":"5209_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12936-023-04610-6","volume":"22","author":"F Conradis-Jansen","year":"2023","unstructured":"Conradis-Jansen F, Tripura R, Peto TJ, Callery JJ, Adhikari B, Ean M, et al. Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications. Malar J. 2023;22:178.","journal-title":"Malar J"},{"key":"5209_CR37","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.92","volume":"44","author":"D Valdez","year":"2020","unstructured":"Valdez D, Keys H, Urena K, Cabral D, Camilo F, Ogando EC, et al. Malaria outbreak response in urban Santo Domingo, Dominican Republic: lessons learned for community engagement. Rev Panam Salud Publica. 2020;44: e92.","journal-title":"Rev Panam Salud Publica"},{"key":"5209_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069170","volume":"8","author":"V Gopichandran","year":"2013","unstructured":"Gopichandran V, Chetlapalli SK. Dimensions and determinants of trust in health care in resource poor settings\u2013a qualitative exploration. PLoS ONE. 2013;8: e69170.","journal-title":"PLoS ONE"},{"issue":"48","key":"5209_CR39","first-page":"58","volume":"2008","author":"PJ Schneider","year":"2003","unstructured":"Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc. 2003;2008(48):58\u201363.","journal-title":"J Am Pharm Assoc"},{"key":"5209_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/8755122517702171","volume":"33","author":"S Shah","year":"2017","unstructured":"Shah S, Galdo J, Cox E, Moreno M, Young H. Impact of bubble packaging on adherence to long-term oral medications used to prevent cardiovascular disease. Journal of Pharmacy Technology. 2017;33:114\u201320.","journal-title":"Journal of Pharmacy Technology"},{"key":"5209_CR41","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.japh.2018.04.022","volume":"58","author":"CL Clifton","year":"2018","unstructured":"Clifton CL, Branham AR, Hayes HH Jr, Moose JS, Rhodes LA, Marciniak MW. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy. J Am Pharm Assoc. 2018;58:S109\u201313.","journal-title":"J Am Pharm Assoc"},{"key":"5209_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taz010","volume":"26","author":"CS Chu","year":"2019","unstructured":"Chu CS, Freedman DO. Tafenoquine and G6PD: a primer for clinicians. J Travel Med. 2019;26:1\u201311.","journal-title":"J Travel Med"},{"key":"5209_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/14656566.2022.2058394","volume":"23","author":"A Llanos-Cuentas","year":"2022","unstructured":"Llanos-Cuentas A, Manrrique P, Rosas-Aguirre A, Herrera S, Hsiang MS. Tafenoquine for the treatment of Plasmodium vivax malaria. Expert Opin Pharmacother. 2022;23:759\u201368.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-024-05209-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T17:04:49Z","timestamp":1734973489000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-024-05209-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5209"],"URL":"https:\/\/doi.org\/10.1186\/s12936-024-05209-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Review Board at the <i>Funda\u00e7\u00e3o de Medicina Tropical Dr Heitor Vieira Dourado<\/i> in Manaus and the National Research Ethics Committee (CONEP) in Bras\u00edlia, Brazil (CAAE: 47598921.2.0000.0005) approved the protocol for both study sites. All participants provided written consent for participation in the study and publication of their de-identified contributions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"PGD is a consultant for MMV Medicines for Malaria Venture. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}